Learn More
Selleck Chemical LLC Anti-KAAG1-D4062-1MG-5

Supplier: Selleck Chemical LLC D40621MG5
Anti-KAAG1 is an ADC composed of a humanized monoclonal antibody (3A4) targeting human KAAG1 It is used for the treatment of advanced solid tumors including platinum resistant ovarian cancer and triple negative breast cancer MW 145 28 KD
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.